英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：


请选择你想看的字典辞典：
单词字典翻译
Kriya查看　Kriya　在百度字典中的解释百度英翻中〔查看〕
Kriya查看　Kriya　在Google字典中的解释Google英翻中〔查看〕
Kriya查看　Kriya　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Kriya Therapeutics: Gene Therapy. Redefined.
    Kriya is a biopharmaceutical company developing gene therapy to address common diseases that impact millions of people worldwide Learn more
  • Pipeline - Kriya Therapeutics
    Kriya is developing a portfolio of one-time gene therapies in ophthalmology, metabolic disease and neurology
  • Kriya Announces $150 Million Addition to its Series C, Bringing Total . . .
    Since its founding in October 2019, Kriya has raised over $600 million in committed capital—and with this financing, Kriya’s cash runway is anticipated to run into late 2026 Kriya is developing a portfolio of transformational gene therapies focused on three main therapeutic areas: ophthalmology, neurology and metabolic disease
  • Careers: Future of Gene Therapy - Kriya Therapeutics
    Careers Kriya is Changing the Future of Gene Therapy We have an ambitious set of goals, but our confidence – and our inspiration – stems from our people From California to North Carolina, our teammates bring creativity, leadership, and a spirit of collaboration to their work every day
  • Research Development - Kriya Therapeutics
    Research Development Historically, innovation in gene therapy has often been driven by research groups with limited in-house capabilities for optimizing and scaling product candidates, leading to challenges when attempting to translate new discoveries into successful clinical studies and commercial product launches Kriya is pioneering a new paradigm for gene therapy R D that empowers our […]
  • Kriya Announces Thirteen Presentations at the American Society of Gene . . .
    Kriya Announces Thirteen Presentations at the American Society of Gene Cell Therapy (ASGCT) Annual Meeting 2025 – Kriya’s platform includes fully integrated best-in-class manufacturing and research capabilities to support parallel advancement of a broad pipeline of gene therapies –
  • Kriya Announces $320 Million Series D Financing to Advance Pipeline of . . .
    About Kriya Therapeutics Our mission is to revolutionize medicine, with the ultimate goal of eliminating human suffering and enabling people to live without the burden of disease Kriya is a clinical-stage biopharmaceutical company developing gene therapies to address chronic diseases affecting millions of people around the world
  • Neurology: Gene Therapy for Trigeminal Neuralgia - Kriya Therapeutics
    Kriya is developing KRIYA‑748, a potential one-time gene therapy for trigeminal neuralgia that expresses a chemogenetically-gated ion channel and is designed to be administered as an injection into the trigeminal nerve, with the objective of reducing the frequency and severity of pain attacks
  • Our Team: Leaders in Gene Therapy - Kriya Therapeutics
    Kriya’s team of gene therapy pioneers and biopharma veterans is building a pipeline to address common diseases
  • Kriya Presents Data at the 2025 Association for Research in Vision and . . .
    KRIYA-825 is designed to be administered through a one-time in-office suprachoroidal injection GA affects approximately two million people in the United States and the European Union Existing treatments require monthly or every-other-month physician-administered intravitreal injections that can be burdensome for patients





中文字典-英文字典  2005-2009